Table 1

Patient characteristics (values are absolute numbers and percent or mean ± standard deviation)

Study population

Responders only


Adults (n = 2,635)

Children (n = 1,074)

Adults (n = 1,903)

Children (n = 819)


Sex (male: female)

771:1864

559:515

518:1385

423:396

Age at study entry (years)

40.6 ± 12.4

6.7 ± 4.1

41.0 ± 12.3

6.5 ± 4.0

Age at 8-year follow-up (years)

48.3 ± 12.4

14.2 ± 4.2

48.8 ± 12.3

14.1 ± 4.2

Marital status (living in partnership)

1916 (72.7%)

1405 (73.9%)

Education (attending school >10 years)

1570 (59.6%)

1155 (60.7%)

Belief in homeopathy at study entry

1744 (66.2%)

739 (68.8%)

1283 (67.4%)

567 (69.2%)

Duration of disease at study entry (years)

10.0 ± 9.6

4.3 ± 2.7

9.8 ± 8.7

4.2 ± 3.5

Intake of conventional drugs at study entry

1318 (50.0%)

340 (31.7%)

965 (50.7%)

273 (33.3%)

Primary diagnosis at study entry *

Allergies (ICD9: 995.3)

154 (5.8%)

65 (6.1%)

114 (6.0%)

51 (6.2%)

Anxiety (ICD9: 300.0)

137 (5.2%)

44 (4.1%)

94 (4.9%)

34 (4.2%)

Asthma (ICD9: 493.9)

109 (4.1%)

67 (6.2%)

88 (4.6%)

51 (6.2%)

Depression (ICD9: 311.0)

157 (6.0%)

5 (0.5%)

110 (5.8%)

2 (0.2%)

Eczema (ICD9: 692.9)

200 (7.6%)

48 (4.5%)

154 (8.1%)

42 (5.1%)

Multiple infections (ICD9: 796.6)

140 (5.3%)

183 (17.0%)

105 (5.5%)

141 (17.2%)

Migraine (ICD9: 346.9)

202 (7.7%)

16 (1.5%)

146 (7.7%)

12 (1.5%)

Atopic dermatitis (ICD9: 691.8)

131 (5.0%)

216 (20.1%)

99 (5.2%)

175 (21.4%)

Allergic rhinitis (ICD9: 477.9)

215 (8.2%)

58 (5.4%)

161 (8.5%)

45 (5.5%)

Headache (ICD9: 784.0)

216 (8.2%)

71 (6.6%)

155 (8.1%)

45 (5.5%)

Sleep disorders (ICD9: 780.5)

185 (7.0%)

77 (7.2%)

127 (6.7%)

58 (7.1%)


* Multiple diagnoses allowed

Witt et al. BMC Public Health 2008 8:413   doi:10.1186/1471-2458-8-413

Open Data